Silk Road Medical, Inc
SILK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $177,134 | $138,638 | $101,475 | $75,227 |
| % Growth | 27.8% | 36.6% | 34.9% | – |
| Cost of Goods Sold | $50,048 | $37,876 | $25,446 | $21,291 |
| Gross Profit | $127,086 | $100,762 | $76,029 | $53,936 |
| % Margin | 71.7% | 72.7% | 74.9% | 71.7% |
| R&D Expenses | $41,324 | $36,449 | $27,110 | $21,271 |
| G&A Expenses | $144,572 | $115,970 | $96,166 | $75,330 |
| SG&A Expenses | $145,033 | $116,317 | $96,387 | $75,524 |
| Sales & Mktg Exp. | $461 | $347 | $221 | $194 |
| Other Operating Expenses | $442 | -$190 | -$23 | -$80 |
| Operating Expenses | $186,357 | $152,766 | $123,497 | $96,795 |
| Operating Income | -$59,271 | -$52,004 | -$47,468 | -$42,859 |
| % Margin | -33.5% | -37.5% | -46.8% | -57% |
| Other Income/Exp. Net | $3,528 | -$3,006 | -$2,343 | -$4,506 |
| Pre-Tax Income | -$55,743 | -$55,010 | -$49,811 | -$47,365 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$55,743 | -$58,016 | -$50,387 | -$50,385 |
| % Margin | -31.5% | -41.8% | -49.7% | -67% |
| EPS | -1.44 | -1.62 | -1.45 | -1.53 |
| % Growth | 11.1% | -11.7% | 5.2% | – |
| EPS Diluted | -1.44 | -1.62 | -1.45 | -1.53 |
| Weighted Avg Shares Out | 38,804 | 35,776 | 34,635 | 32,966 |
| Weighted Avg Shares Out Dil | 38,804 | 35,776 | 34,635 | 32,966 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,957 | $2,527 | $198 | $1,104 |
| Interest Expense | $6,871 | $5,098 | $2,518 | $4,411 |
| Depreciation & Amortization | $3,792 | $3,168 | $1,919 | $1,391 |
| EBITDA | -$45,080 | -$46,744 | -$45,549 | -$41,468 |
| % Margin | -25.4% | -33.7% | -44.9% | -55.1% |